Jaime S. King
Jaime S. King is the John and Marylyn Mayo Chair in Health Law and Professor of Law at the University of Auckland in New Zealand. Prior to joining the University of Auckland, Professor King was the Bion M. Gregory Chair of Business Law and a Professor of Law at the University of California Hastings College of the Law. She served as the Associate Dean and Co-Director of the UCSF/UC Hastings Consortium on Law, Science, and Health Policy, the Co-Founder and Co-Director of the UCSF/UC Hastings Master’s Program in Health Law and Policy, and the Director of the J.D. Concentration on Law and Health Sciences.
Professor King is an expert in healthcare reform, specializing in some of the most complex challenges facing the U.S. healthcare system. Her current research focuses on the drivers of healthcare costs, with a special interest in market consolidation and efforts to improve transparency in healthcare pricing. Her past scholarship has also addressed questions of individual autonomy and the states’ police power, including but not limited to medical decision making and constitutional and regulatory questions regarding reproductive genetic testing.
In 2015, Professor King testified before the House Judiciary Subcommittee on Regulatory Reform, Commercial, and Antitrust Law on issues surrounding proposed health insurance mergers. She again testified in 2018 before the U.S. House of Representatives Subcommittee on Oversight and Investigations on state efforts to improve transparency in healthcare costs. Professor King is also a co-author of the 8th edition casebook of Health Law Cases and Problems. Currently, Professor King is a board member and the immediate Past President of the Board of the American Society of Law, Medicine, and Ethics.
As Hospitals Grow, So Does Your Bill
How Will Draft Merger Guidelines Impact Health Care Markets?
Considerations for state-imposed conditions on healthcare provider transactions
A Step Forward for Health Care Market Oversight: Oregon Health Authority’s Health Care Market Oversight Program
Antitrust’s Healthcare Conundrum: Cross-Market Mergers and the Rise of System Power
Challenging Anticompetitive Cross-Market Health Mergers
The Rise Of Cross-Market Hospital Systems And Their Market Power In The US
Can Taxes Help Address High Health Care Prices?
Are State Public Option Health Plans Worth It?
Mitigating the Price Impacts of Health Care Provider Consolidation
State Public Option Plans — Too Modest to Improve Affordability?
State Action to Oversee Consolidation of Health Care Providers
The Drivers of U.S. Health Care Spending
California’s Sutter Health Settlement: What States Can Learn About Protecting Residents from the Effects of Health Care Provider Consolidation
Preventing Anticompetitive Contracting Practices in Healthcare Markets
A Lesson from States: Curtailing Anticompetitive Health Care Consolidation
California seeks more power to fight healthcare mergers
2020 Report Card on State Price Transparency Laws
Perspective: Covid-19 and the Need for Health Care Reform
California State Assembly on Health: Hearing on Cost Containment
Tradeoffs Podcast: The Train Has Left the Station
Antitrust case against Sutter Health due to begin this week
High Medical Bills Are at Center of Hospital Group’s Trial
Navigating Legal Challenges to State Efforts to Control Drug Prices
Sutter Antitrust Class Action Could Upend Industry Consolidation